Manny Machado, Zach Britton, Brad Brach, Kevin Gausman, Darren O’Day and now Jonathan Schoop. After trading each of them, the Baltimore Orioles are now in full-on rebuild mode.
And while the Milwaukee Brewers didn’t add to their rotation Tuesday, they didn’t stay completely quiet either. Per MLB.com’s Mark Feinsand, Schoop didn’t come cheap for the Brewers. And yet, he didn’t cost as much as some might think.
“Orioles’ return for Schoop: Brewers’ No. 7 prospect (RHP Luis Ortiz) and No. 14 prospect (SS Jean Carmona). Plus Jonathan Villar.”
For what it’s worth, Milwaukee’s farm system isn’t nearly as strong as it was before they dealt for Christian Yelich this past winter. Ortiz could be good, but his stock was falling. This year marked his second season at Double-A Biloxi and he wasn’t making much progress. That said, it might be difficult to get too excited about Schoop.
He’s having a great month of July, slashing .356/.360/.700 with seven doubles and nine home runs, but he’s hitting just .244/.273/.447 on the year with a below average wRC+ (90). Last year, he hit .293/.338/.503 (.841 OPS) with 35 doubles and 32 home runs. That’s the player the Brewers are hoping to have for the second half of the season. The fact that he’s hitting the ball hard just 26.6 percent of the time, however, is troubling.
It also begs the question: where is Schoop going to play?
Despite logging 2,000 innings at shortstop in the minors, Schoop is a second baseman. If the Brewers don’t option Orlando Arcia back to Triple-A, does he platoon with Travis Shaw at second base? We ask because just last weekend, Milwaukee acquired third baseman Mike Moustakas from the Kansas City Royals.
Having solid bats off the bench certainly won’t be an issue for manager Craig Counsell the rest of the way, but it’s going to be interesting to see how this all plays out. Right now the Brewers find themselves just one game back of the Chicago Cubs in the NL Central. They are 2.5 games up on the Arizona Diamondbacks for the first wild card spot.
Does Schoop move the needle all that much?